We examined bone marrow from myeloma patients for the presence of cells with the characteristics of the clonogenic cell in the myeloma stem cell assay. We identified a novel type of cell that contained cytoplasmic immunoglobulin of the relevant idiotype located in a cytoplasmic spot. This "spotted" Ig could be located in the rough endoplasmic reticulum. Spotted cells are highly proliferative, as evidenced by the nuclear staining with the antibody Ki67, and were found in the bone marrow from most of the myeloma patients studied. This type of cell was also present in patients with immunocytomas, in some cases of benign monoclonal gammopathy, and in patients in the state of polyclonal hypergammaglobulinemia. 
Introduction
In most cases of multiple myeloma (MM)' a homogeneous immunoglobulin (Ig) fraction is found in the serum, and is accompanied by an increase ofplasma cells in the bone marrow (BM), most ofwhich produce Ig of identical heavy and light chain and of the same idiotype (Id) as the monoclonal serum component.
The presence of Id' peripheral B cells (1) (2) (3) and of Id' pre-B cells (1) in the bone marrow of patients with MM suggests that the oncogenic event has not taken place at the level ofthe mature Id+ plasma cell, but rather at the level of the more immature Id' B lymphocyte or even at the level of the Id+ pre-B cell. The clonal expansion in MM, however, is probably due to proliferation of more mature plasmacytoid cells. This is apparent from the incorporation of tritiated thymidine in a subpopulation of MM bone marrow plasma cells (4) . In addition, recent observations in our laboratory have shown that the colony-forming cells in the myeloma stem cell assay, as described by Hamburger and Salmon (5), could be found in BM fractions enriched for small plasmacytoid cells bearing transferrin receptors (TrfR) (6, 7) . When we searched in the BM of MM patients for cells fulfilling these criteria, we were able to identify a novel type of lymphoplasmacytoid cell. This particular cell type is only weakly positive for cytoplasmic Ig, which is concentrated in a small cytoplasmic area-an extremely swollen rough endoplasmatic reticulum (RER) cisterna-resulting in a spotted pattern of immunofluorescent staining. This cell type is actively cyclic since a high percentage of these cells incorporate [3H]thymidine (TdR) and almost all spotted cells express the membrane receptor for transferrin and the nuclear antigen detected by Ki67, which is associated with cell proliferation (8) . Using various clustered (Leucocyte Typing Workshop in Paris, France [9] and Boston, MA [10] ) and nonclustered antibodies reacting with B cells in various stages of differentiation, this spotted cell was found to be intermediate between B lymphocytes and plasma cells.
Methods
Patients. Patients were defined according to the Chronic Leukemia Myeloma Task Force of the National Cancer Institute (Bethesda, MD) (1 1). 31 untreated patients with MM were studied: 18 males and 13 females (age yr). 20 had monoclonal IgG and 7 IgA. The light chains were Kin 20 cases and X in the remaining 7. Four patients secreted light chains only (3 K and I X). Three patients were in stage IA, three in stage IIA, twenty-one in stage IIIA, and four in stage 111B. One patient (male, aged 68) had a plasma cell leukemia (PCL). Two patients with biclonal gammopathy (one IgAK and IgGK, another "pseudo" case, in which the IgGlK and IgG4K expressed the same Id) have been described elsewhere (12) . 26 patients (12 male, 14 female, aged 43-74) had benign monoclonal gammopathy (BMG). In these last cases, the levels of monoclonal Ig were < 20 g/liter, with < 10% plasma cells in the BM. Eight patients (three male, five female, aged 41-73) had immunocytoma.
Cells studied. The samples examined were: (a) BM aspirates from 31 untreated patients with MM, from 26 patients with BMG, and from 8 patients with immunocytoma; (b) Peripheral blood lymphocytes (PBL) from the patient with PCL, from four patients with MM, and from six patients with immunocytoma. BM samples of four patients with no Preparation ofthe cells. Mononuclear cells were separated from blood and BM on Ficoll-Hypaque. The cells in the interphase were washed twice with minimum essential medium (MEM; Gibco, Grand Island, NY). In some cases, nucleated cells from the BM were obtained after isotonic NH4Cl lysis of the erythrocytes. Where tested, both methods of isolation gave similar results. Cells were resuspended in MEM containing 10% fetal calf serum (Gibco; unselected batches).
Antibodies. The rabbit (R) and goat (G) affinity-purified antibodies with fluorescein or tetramethylrhodamine isothiocyanate (FITC or TRITC) conjugated to human Ig isotypes (a, y, IA, K, X) have been described previously (13) . The TRITC-or biotin-conjugated monoclonal anti-y 123 and anti--y4 antibodies have also been described (12) . Affinitypurified R anti-Id antibodies used for patients Koe and Tim, conjugated with biotin or FITC, have been described earlier (12) . The monoclonal anti-Id antibody used for patient He has been described earlier (14 Immunoelectron microscopic evaluation ofthe spotted cells. For the ultrastructural investigation of spotted cells, the purified mononuclear BM cells (106) were fixed in 1% acrolein (Polysciences, Inc., Warrington, PA) and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, for 1 h at 4°C. After removal of the fixative by centrifugation, the cells were washed in 0.1 M phosphate buffer. Washed cells were spun down, suspended in gelatin (10%) that was allowed to solidify as a thin slab at 4°C on a petri disk, and fixed again for 30 min to introduce crosslinking of the gelatin molecules. The cells could be stored afterwards for a few weeks in 0.1 M phosphate buffer.
For immunoelectron microscopic (EM) studies, tissue blocks were immersed in 2.3 M sucrose for at least 30 min and frozen in liquid nitrogen. Ultrathin cryosections made by an LKB Nova ultramicrotome equipped with LKB Cryonova were prepared according to the Tokayasa method (42) and indirectly labeled with protein A-colloidal gold probes as described by Geuze et al. (43) . Gold particles were prepared by a new tannic acid/citrate reduction procedure described by Slot and Geuze (44) and complexed to protein A (Pharmacia Fine Chemicals, Piscataway, NJ) according to the description by Slot and Geuze (45) . For the detection of the transferrin receptor, cells were incubated before fixation with the monoclonal anti-TrfR antibody. To detect these MoAbs the cryosections were incubated with R anti-M Ig followed by protein A gold complex (6 nm).
For the detection of galactosyl transferase, the cryosections were incubated with R anti-human galactosyl transferase (1:500) followed by protein A gold complex (6 nm). After the first immunolabeling for either the TrfR or the enzyme galactosyl transferase, the cryosections were incubated with unconjugated protein A before the application of the second antibody (i.e., anti-immunoglobulin) to detect the immunoglobulin in the spotted cell, which was then visualized with protein A gold (9 nm (Fig. 1 a) . Because of their small content of cytoplasmic Ig, optimal conditions for fluorescence microscopy are required for the identification of spotted cells. In our procedure, the use of affinitypurified antibody conjugates was essential in this respect.
Almost all spotted cells express TrfR (Fig. 1 c) , and a major proportion of these cells incorporate [3H]TdR during a 1-h incubation period (Table II and Fig. 1 b) . In contrast, genuine plasma cells express these markers of proliferation only in low percentages (Table II) .
Spotted localization of cytoplasmic Ig was also demonstrated using the APAAP method and differs from diffuse cytoplasmic staining in plasma cells (Fig. 2) . This method was combined with immunoperoxidase staining for the detection of Ki67-positive, cytoplasmic Ig-containing cells (Fig. 2) . In that way, this nuclear antigen, associated with cellular proliferation, was found in a high proportion of spotted cells (Table III) . Also, the fluorescence pattern of spotted cells is different from that seen in the diffuse cytoplasmic staining of plasma cells (Fig. 3 a) .
Characterization ofspotted cells. The spotted cells were further characterized in four aspects. In the first phase, the expression of Ig determinants was analyzed. In the three cases tested, the Id of the spot-located Ig was identical to that of the Ig in the majority of plasma cells (Table II) , which indicated that these spotted cells belong to the malignant clone. Also the H and L chain isotype of the spotted cells was identical to that of the monoclonal plasma cells. In a patient with pseudo biclonal gammopathy (12) (both monoclonal Ig components in the serum expressing the same Id), the subclass distribution within the population ofplasma cells and within the spotted cells was similar (Table IV) . Secondly, the immunological phenotype ofthe spotted cells, as defined by the expression of various leukocyte differentiation antigens, was determined. Spotted cells were considered to be positive when > 50% (in most cases > 80%) of the cells expressed the marker studied. Positive cells were never > 5% for the markers considered to be negative. For each marker, BM samples from at least three different patients were tested. As far as tested, spotted cells do not express T cell and myelomonocytic antigens, as shown in Table V . The cells are also negative for the B cell-associated (mainly CD) antigens, the plasmacytoid antigens tested, and HLA-DR. They are, however, positive for the B cell-associated antigens HB4 (23) and HB6 (24) .
Thirdly, in fluorescent co-staining experiments, the spotted Ig appeared to be in the same place as the enzyme galactosyl transferase (Fig. 3, a and b) . Fourthly, the immuno-EM study was used to characterize the morphologic feature of the spotted cell and in particular to investigate the type of organelle that gives the typical spotted appearance in the fluorescence microscope. In these EM studies, Ig-containing cells expressing TrfR were found in -0.2% of the cells in the BM sample studied (in IF the percentage of malignant plasma cells and spotted cells in this sample were 29 and 0.5%, respectively). In Fig. 4 a the morphology of the spotted cell is shown. This cell appears to be lymphocytic; the nucleus is very similar to that of a plasma cell and in the cytoplasm a large structure with a diffuse matrix is found. This structure contains ribosomes on the membrane, which makes it evident that it belongs to the RER (Fig. 4 b) . The dilated cisternae of the RER are striking. Obviously, one of the cisternae is extremely swollen; this is in contrast to malignant plasma cells, where multiple swollen cisternae are found, and to normal plasma cells, where only smaller cisternae are present (46) . With immunolabeling at ultrastructural level we compared the fluorescence studies with ultrastructural studies. Firstly, in immuno-EM, TrfR-positive cells were also detected; due to the rapid turnover of TrfR (47) these TrfR were demonstrated in endocytotic vesicles, which also contained some Ig (Fig. 5) . In these cells, TrfR were not found in the RER or the Golgi complex (Fig. 6 ). Plasma cells did not express TrfR (data not shown). Secondly, there is no co-labeling of immunoglobulin and TrfR in the spotted structure (Fig. 7 a) indicating that it is no part of Table II and reference 12). Spotted cells expressing these two subclasses simultaneously also occur. The proportional distribution of these three cell types within the plasma cells and spotted cells is similar.
the endocytotic route. This is confirmed by the presence ofboth galactosyl transferase and Ig in this structure (Fig. 7 b) , since this enzyme was never found in endocytotic vesicles but only in RER and Golgi complex (15, 16) . There is no background labeling, as can be seen over the mitochondria and nucleus (Fig. 5) .
Occurrence of spotted cells. The results presented in Fig. 8 show that spotted cells are not restricted to malignancy. However, the incidence in untreated MM patients is much higher than in BMG. In 24 out of 31 MM patients (=77.4%), spotted cells were found above the limit ofdetection (0.25%) in the BM, mean 1.9 (range 0.25 to 4.5), and in only 6 out of 24 patients (=31.3%) with BMG, mean 1.6 (range 0.25 to 2.5). Spotted cells were also identified in the bone marrow of three out of four patients with polyclonal hyperglobulinemia (PHG) . Spotted cells were found in all eight patients with immunocytoma.
In the case of PCL tested, spotted cells were present in the peripheral blood, whereas these cells could not be identified in PBL samples from MM patients or in patients with immunocytoma without peripheral plasma cells.
Discussion
An apparently novel cell type of the B cell lineage was detected when we searched in the bone marrow of patients with MM for cells that expressed the characteristics of the clonogenic cell as defined in the myeloma stem cell assay. Prior experiments (6, 7) indicated that these clonogenic cells are smaller (as compared with mature plasma cells) Id' plasmacytoid cells and show markers of proliferation like [3H]thymidine incorporation and the expression of TrfR. Apart from a low percentage of apparently proliferating, "genuine" plasma cells, we found another type of cytoplasmic Ig-containing cell that expressed these proliferation markers in a far greater proportion. In this particular cell the cytoplasmatic Ig was located in a distinct way; it was detected as a single spot in the cytoplasm.
After identification in the immunofluorescent staining procedure, this so-called spotted cell could also be found in the double immunoenzymatic labeling technique, combining the immunoperoxidase with the APAAP method for the detection of Ki67-positive cytoplasmic Ig-containing cells. This also confirmed the highly proliferative state of the spotted cells, as the greater majority stained with the Moab Ki67.
The Ig ofthe spotted cells is located in the extremely swollen RER cisternae, as shown in the EM studies. Spotted cells express TrfR, whereas plasma cells lack this marker. This TrfR was only found in the endocytotic vesicles and not in the RER and the Golgi. In contrast, Ig and galactosyl transferase, present in the same compartment as shown by IF, were found together only in the RER and the Golgi complex. These specific locations offer a strong argument for the endogenous origin of the spotted Ig. Artifactual endocytosis ofmembrane-bound Ig or exogenous Ig as the cause of spotted Ig staining could be further excluded, as pronase treatment for the removal ofcell surface determinants or the presence of azide (0.1%) throughout the whole procedure-from the collection of the BM to the preparation of cytocentrifuged slides-did not affect this spotted Ig staining pattern (unpublished results). Immunocytochemical localization of immunoglobulins, transferrin receptor, and galactosyl transferase in ultrathin cryosections of spotted cells. Cells were incubated with B3-25, washed, and fixed with 1% acrolein and 0.2% glutaraldehyde. Ultrathin cryosections were incubated with either R anti-M Ig and protein A gold (6 nm), to localize the B3-25 MoAb, or with R antihuman galactosyl transferase and protein A gold (6 nm) in both cases followed by incubation with R anti-human Ig and protein A gold (9 nm) . All micrographs were made at magnification x 31,000. M, mitochondria; N, nucleus. (Fig. 5 ): In endocytotic vesicles (E), both immunoglobulin (9 nm of gold particles) and transferrin receptor (6 nm of gold particles; arrowheads) are present.
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Lokhorst et al. (48, 49) or secretion (50) has been described earlier.
Spotted cells evidently belong to the malignant clone in the MM patients. Still, the spotted immunofluorescence pattern of Ig staining may not identify a tumor-specific marker ofmalignant transformation, but rather may depict a cell at a distinct stage in normal B cell differentiation. Spotted cells were also found, although at a much lower frequency, in the bone marrow of patients with BMG and in cases of PHG. As the incidence of spotted cells found in patients with MM was higher than in BMG, this phenomenon may be helpful in the differential diagnosis between these two entities. The clinical significance of spotted cells for the classification of MG, in comparison with the plasma cell LI (40) and the plasma cellular growth fraction, as determined by the MoAb Ki67 (8) , is currently under study.
The functional role of spotted cells has to be discussed in the context of malignant B cell differentiation in myeloma. Selfrenewing plasma cells in MM do occur (4), but do not seem to be the sole source Another type of B lymphoid cell has also been described in MM patients; i.e., a CD10-bearing cell (52 Figure 6 . In the Golgi complex (G) and in RER (R), immunoglobulin (9 nm of gold particles), but no transferrin receptor (6 nm of gold particles), is present. See legend to Figures 5-7 for further detail. 
